Page last updated: 2024-08-23

alovudine and Hyperplasia, Reactive Lymphoid

alovudine has been researched along with Hyperplasia, Reactive Lymphoid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bussink, J; Kaanders, JH; Marres, HA; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ; Vogel, WV	1

Trials

1 trial(s) available for alovudine and Hyperplasia, Reactive Lymphoid

Article	Year
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Pseudolymphoma; Radiopharmaceuticals; Treatment Outcome	2007

Article

Year

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Pseudolymphoma; Radiopharmaceuticals; Treatment Outcome

2007